MMP-13 inhibitors (PharmaHungary/InFarmatik/TargetEx)

N/A

Report date: 2025/03/20 15:56:50
NME

Base Information

Drug NameMMP-13 inhibitors (PharmaHungary/InFarmatik/TargetEx)
Drug Alias Namemetalloproteinase-13 inhibitors (MMPharma consortium)matrix metalloproteinase-13 inhibitors (PharmaHungary/InFarmatik/TargetEx)MMP-13 inhibitors (MMPharma consortium)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 13 inhibitors
TargetsMatrix metalloproteinase 13
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmahungary Group
China Registration ClassN/A

Develop Information

Active CompaniesTargetEXInFarmatik IncPharmahungary Group
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A